|
GABARAPL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62647673107585E-12 |
| Normal-vs-Stage2 |
3.23030000526359E-08 |
| Normal-vs-Stage3 |
1.62436730732907E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
6.785600E-01 |
| Stage1-vs-Stage3 |
2.71909999960407E-07 |
| Stage1-vs-Stage4 |
2.29489999999943E-05 |
| Stage2-vs-Stage3 |
6.123800E-03 |
| Stage2-vs-Stage4 |
9.442300E-03 |
| Stage3-vs-Stage4 |
8.870400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
4.50729453760346E-11 |
| Normal-vs-Asian |
4.354300E-04 |
| Caucasian-vs-AfricanAmerican |
1.367990E-01 |
| Caucasian-vs-Asian |
9.760000E-01 |
| AfricanAmerican-vs-Asian |
5.858400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
2.44249065417534E-15 |
| Male-vs-Female |
3.684500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.57109999957095E-09 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
9.000000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.453600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.513000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.019800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.774600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.245200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.462400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.319220E-03 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62458935193399E-12 |
| Grade 1-vs-Grade 2 |
3.280000E-01 |
| Grade 1-vs-Grade 3 |
8.875600E-03 |
| Grade 1-vs-Grade 4 |
1.93523999999501E-05 |
| Grade 2-vs-Grade 3 |
5.56339999999711E-05 |
| Grade 2-vs-Grade 4 |
8.30240320937037E-11 |
| Grade 3-vs-Grade 4 |
7.398700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.63125069008174E-12 |
| Normal-vs-ccB subtype |
1.62447832963153E-12 |
| ccA subtype-vs-ccB subtype |
2.573500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
3.35609318113939E-12 |
| N0-vs-N1 |
1.919530E-02 |
|
|
